MEDICAL IMPLANTS WITH IMPROVED ROUGHNESS
20200113700 ยท 2020-04-16
Inventors
Cpc classification
A61L2400/18
HUMAN NECESSITIES
A61L2400/12
HUMAN NECESSITIES
A61F2310/00407
HUMAN NECESSITIES
A61F2/30771
HUMAN NECESSITIES
A61L31/14
HUMAN NECESSITIES
International classification
Abstract
A medical implant has a hierarchical surface roughness and includes an implant body, which includes a combination of meso-scale surface features, micro-scale surface features, and nano-scale surface features.
Claims
1. A medical implant having a hierarchical surface roughness, comprising: an implant body including a combination of meso-scale surface features, micro-scale surface features, and nano-scale surface features.
2. The medical implant of claim 1, wherein the meso-scale surface features have sizes in a range of 5 m to 1 mm.
3. The medical implant of claim 2, wherein the meso-scale surface features have sizes in a range of 5 m to 200 m.
4. The medical implant of claim 1, wherein the meso-scale surface features include protruding structures.
5. The medical implant of claim 4, wherein the protruding structures have lateral sizes in a range of 5 m to 200 m, and heights in a range of 5 m to 200 m.
6. The medical implant of claim 4, wherein the protruding structures include cone-shaped, nodule-shaped, pyramid-shaped, trapezoidal, hemispherical, or hemispheroidal structures.
7. The medical implant of claim 1, wherein the micro-scale surface features have sizes in a range of 1 m to 5 m.
8. The medical implant of claim 1, wherein the nano-scale surface features have sizes in a range up to 1 m.
9. The medical implant of claim 8, wherein the nano-scale surface features have sizes in a range of 10 nm to 1 m.
10. The medical implant of claim 1, wherein the nano-scale surface features include protruding structures.
11. The medical implant of claim 1, wherein the nano-scale surface features include compartmental structures.
12. The medical implant of claim 1, wherein the nano-scale surface features and the micro-scale surface features are superimposed onto the meso-scale surface features.
13. The medical implant of claim 1, wherein the medical implant is a metallic implant.
14. The medical implant of claim 13, wherein the metallic implant is a titanium or titanium alloy implant.
15. A medical implant, comprising: an implant body including a surface characterized by an average roughness (R.sub.a) of 1.5 m or greater.
16. The medical implant of claim 15, wherein R.sub.a is 2 m or greater.
17. The medical implant of claim 15, wherein R.sub.a is 2.5 m or greater.
18. A medical implant, comprising: an implant body including a surface characterized by an average peak-to-valley roughness (R.sub.z) of 7 m or greater.
19. The medical implant of claim 18, wherein R.sub.z is 8 m or greater.
20. The medical implant of claim 18, wherein R.sub.z is 10 m or greater.
21. A medical implant, comprising: an implant body including a surface characterized by an average slope of roughness profile (R.sub.a) of 0.21 or greater.
22. The medical implant of claim 21, wherein R.sub.a is 0.23 or greater.
23. The medical implant of claim 21, wherein R.sub.a is 0.25 or greater.
24. A medical implant, comprising: an implant body including a surface characterized by: (a) an average roughness (R.sub.a) of 1.5 m or greater; (b) an average peak-to-valley roughness (R.sub.z) of 7 m or greater; and (c) an average slope of roughness profile (R.sub.a) of 0.21 or greater.
25. The medical implant of claim 24, wherein R.sub.a is 2.5 m or greater, R.sub.z is 10 m or greater, and R.sub.a is 0.25 or greater.
26. A method of forming a medical implant having a hierarchical surface roughness, comprising subjecting the medical implant to surface treatment by exposing the medical implant to an etching liquid while generating bubbles within the etching liquid.
27. The method of claim 26, wherein the etching liquid includes an acid.
28. The method of claim 26, wherein exposing the medical implant to the etching liquid includes disposing an auxiliary material within the etching liquid, and disposing the medical implant over the auxiliary material.
29. The method of claim 28, wherein the auxiliary material is the same as a material of the medical implant.
30. The method of claim 28, wherein the auxiliary material is different than a material of the medical implant.
31. The method of claim 26, wherein exposing the medical implant to the etching liquid is carried out at a temperature of 140 C. or higher.
32. The method of claim 31, wherein exposing the medical implant to the etching liquid further includes disposing an auxiliary material within the etching liquid, and disposing the medical implant over the auxiliary material.
33. The method of claim 26, wherein exposing the medical implant to the etching liquid is carried out while agitating the etching liquid using an agitator.
34. The method of claim 33, wherein the agitator is an ultrasonic device.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0026] For a better understanding of the nature and objects of some embodiments of this disclosure, reference should be made to the following detailed description taken in conjunction with the accompanying drawings.
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
DETAILED DESCRIPTION
[0038] Besides various macroscopic designs, other titanium implants have micro-scale (scale between about 1 m and about 5 m) topography to promote bone-implant integration. To further improve titanium implants, adding meso-scale (scale between about 5 m to about 200 m) surface roughness can enhance a mechanical interlocking between titanium and bone, while adding nano-scale (scale up to about 1 m or less) surface roughness can further promote the function of bone-forming cells. Here some embodiments are directed to the formation of an improved titanium surface with hierarchical morphology of meso-, micro- and nano-scale structures. Titanium implants with this hierarchical surface roughness have been demonstrated to show greater strength of bone-implant integration than titanium implants with micro-scale topography alone.
[0039] Provided herein are medical implants for enhancing bone-implant integration capabilities.
[0040] In some embodiments, the medical implant 100 having the hierarchical surface roughness is characterized by, according to surface profiling using a profilometer, one or a combination of two or more of the following: (1) an average roughness (R.sub.a) (arithmetic average of absolute values of vertical deviations of a surface profile about a mean line within a sampling length) in a range of about 1.2 m or greater, such as about 1.3 m or greater, about 1.5 m or greater, about 1.8 m or greater, about 2 m or greater, about 2.3 m or greater, or about 2.5 m or greater, and up to about 8 m or greater, or up to about 10 m or greater; (2) an average peak-to-valley roughness (R.sub.z or R.sub.p-v) (arithmetic average of vertical distances between peaks and valleys of a surface profile within a sampling length) in a range of about 6.5 m or greater, such as about 7 m or greater, about 7.5 m or greater, about 8 m or greater, about 8.5 m or greater, about 9 m or greater, about 9.5 m or greater, or about 10 m or greater, and up to about 15 m or greater, or up to about 20 m or greater; and (3) an average slope of roughness profile (R.sub.a) (arithmetic average of absolute values of a slope of a surface profile within a sampling length) in a range of about 0.2 or greater, such as about 0.21 or greater, about 0.22 or greater, about 0.23 or greater, about 0.24 or greater, or about 0.25 or greater, and up to about 0.5 or greater, or up to about 0.8 or greater.
[0041] In some embodiments, the medical implant 100 is a metallic implant including one or more metals, such as a titanium implant. Other examples of metallic implants include titanium alloy implants, chromium-cobalt alloy implants, platinum and platinum alloy implants, nickel and nickel alloy implants, stainless steel implants, zirconium implants, zirconia implants, titanium-zirconia alloy implants, gold or gold alloy implants, and aluminum or aluminum alloy implants. In other embodiments, the medical implant 100 is a non-metallic implant. Examples of non-metallic implants include ceramic implants, calcium phosphate implants, and polymeric implants.
[0042] Also provided herein are methods of forming medical implants having a hierarchical surface roughness. In some embodiments, a method includes subjecting a medical implant to surface treatment by exposing the medical implant to an etching liquid while generating bubbles within the etching liquid. In some embodiments, the etching liquid includes an acid, such as sulfuric acid (H.sub.2SO.sub.4) or another strong acid. In some embodiments, exposing the medical implant to the etching liquid is carried out for a time period in a range of 5 seconds to about 10 minutes, such as about 5 seconds to about 5 minutes, about 10 seconds to about 5 minutes, about 10 seconds to about 3 minutes, or about 10 seconds to about 2 minutes. In some embodiments, exposing the medical implant to the etching liquid is carried out at a temperature in a range of about 100 C. to about 140 C., such as about 110 C. to about 130 C., or about 120 C. Other manners of surface treatment are contemplated in place of, or in combination with, acid treatment, such as alkaline treatment, oxidation, light irradiation, material deposition (e.g., sputtering, plasma spraying, or vapor deposition), and physical treatments like laser-etching, machining, or sandblasting. For example, laser-etching can be performed to yield meso-scale surface features, along with acid treatment to yield micro- and nano-scale surface features.
[0043] In some embodiments, generation of bubbles is promoted by disposing an auxiliary material within the etching liquid, such as within a container, and disposing the medical implant over the auxiliary material. In some embodiments, the auxiliary material is or includes a same or similar material as that of the medical implant, such as titanium or another metal or combination of metals. In some embodiments, the auxiliary material is or includes a different material as that of the medical implant. The auxiliary material can be in the form of fibers, a rod, a wire, an array, coil, or stack of the foregoing, or a disk or a cylinder. In some embodiments, the inclusion of the auxiliary material promotes vigorous, accelerated, and enhanced flow of the etching liquid and promotes generation of bubbles. In some embodiments, the bubbles are generated via a chemical reaction between the auxiliary material and the etching liquid, and at least some of the bubbles impinge upon or bombard a surface of the medical implant to impart a hierarchical surface roughness.
[0044] In some embodiments, generation of bubbles is promoted by exposing the medical implant to the etching liquid at an elevated temperature in a range of about 140 C. or higher, such as about 140 C. to about 160 C., or about 140 C. In some embodiments, the elevated temperature promotes vigorous, accelerated, and enhanced flow of the etching liquid and promotes generation of bubbles. In some embodiments, the bubbles are generated via a chemical reaction between the medical implant and the etching liquid, and at least some of the bubbles impinge upon or bombard the surface of the medical implant to impart the hierarchical surface roughness. In some embodiments, generation of the bubbles is promoted by exposing the medical implant to the etching liquid at an elevated temperature, along with disposing an auxiliary material within the etching liquid.
[0045] Other manners of promoting the flow of the etching liquid and generation of bubbles are contemplated, such as by agitating the etching liquid using a mechanical agitator, such as an ultrasonic device or a mechanical vibrator. Also, combinations of two or more of the foregoing surface treatments are contemplated, such as using two or more of an auxiliary material, an elevated temperature, material deposition, laser-etching, and agitation.
[0046] In some embodiments, the medical implant (or another reference medical implant) prior to surface treatment has, according to a large scale (=250 m) surface profiling, a reference average roughness (R.sub.a), a reference maximum peak-to-valley roughness (R.sub.max), a reference average width of roughness profile elements (R.sub.sm), a reference skewness of roughness profile (R.sub.sk), and a reference kurtosis of roughness profile (R.sub.ku), and the medical implant subsequent to surface treatment has, according to the large scale (=250 m) surface profiling, an average roughness (R.sub.a) greater than the corresponding reference value, a maximum peak-to-valley roughness (R.sub.max) greater than the corresponding reference value, an average width of roughness profile elements (R.sub.sm) greater than the corresponding reference value, a skewness of roughness profile (R.sub.sk) smaller than the corresponding reference value, and a kurtosis of roughness profile (R.sub.ku) smaller than the corresponding reference value.
[0047] In some embodiments, the medical implant (or another reference medical implant) prior to surface treatment has, according to a small scale (=0.25 m) surface profiling, a reference average roughness (R.sub.a), a reference maximum peak-to-valley roughness (R.sub.max), a reference average width of roughness profile elements (R.sub.sm), a reference skewness of roughness profile (R.sub.sk), and a reference kurtosis of roughness profile (R.sub.h), and the medical implant subsequent to surface treatment has, according to the small scale (=0.25 m) surface profiling, an average roughness (R.sub.a) smaller than the corresponding reference value, a maximum peak-to-valley roughness (R.sub.max) smaller than the corresponding reference value, an average width of roughness profile elements (R.sub.sm) smaller than the corresponding reference value, a skewness of roughness profile (R.sub.sk) smaller than the corresponding reference value, and a kurtosis of roughness profile (R.sub.ku) smaller than the corresponding reference value.
[0048] The medical implant provided herein can be used for treating, preventing, ameliorating, correcting, or reducing one or more symptoms of a medical condition by implanting the medical implant in a mammalian subject. The mammalian subject can be a human or a veterinary animal such as a dog, a cat, a horse, a cow, a bull, or a monkey. Examples of medical conditions that can be treated or prevented include missing teeth or bone related medical conditions such as femoral neck fracture, orthodontic anchorage, wrist fracture, spine fracture/disorder, spinal disk displacement, edentulous jaw, fracture or degenerative changes of joints such as knee joint arthritis, bone and other tissue defect or recession caused by a disorder or a body condition such as cancer, injury, systemic metabolism, infection or aging, and combinations thereof.
EXAMPLES
[0049] The following examples describe specific aspects of some embodiments of this disclosure to illustrate and provide a description for those of ordinary skill in the art. The examples should not be construed as limiting this disclosure, as the examples merely provide specific methodology useful in understanding and practicing some embodiments of this disclosure.
Example 1
[0050] Results
[0051] Surface Morphology of Micro-Scale Rough Titanium and Hierarchically Rough Titanium Surfaces
[0052]
[0053]
[0054]
[0055]
[0056] Surface Profiles of Micro-Scale Rough Titanium and Hierarchically Rough Titanium Surfaces
[0057]
[0058]
[0059] Roughness and Profile Parameters of Micro-Scale Rough Titanium and Hierarchically Rough Titanium Surfaces
[0060]
[0061]
[0062] Strength of Bone-Implant Integration for Micro-Scale Rough Titanium and Hierarchically Rough Titanium
[0063]
[0064] Methods to Form Hierarchically Rough Titanium Surface
[0065] Method 1: Using Auxiliary Titanium
[0066] About 30 ml of H.sub.2SO.sub.4 (about 66% concentration) is heated to about 120 C. Commercially pure titanium wire (about 1 mm diameter, about 90 cm in length) in a coil form is submerged in the heated H.sub.2SO.sub.4. After confirming a chemical reaction is started and bubbles are vigorously generated, titanium implants or other titanium samples of interest are soaked into H.sub.2SO.sub.4 for about 75 seconds. Titanium implants are removed and rinsed with double-distilled H.sub.2O.
[0067] Method 2: Using High-Temperature Acid
[0068] About 30 ml of H.sub.2SO.sub.4 (about 66% concentration) was heated to about 140 C. or higher. Titanium implants or other titanium samples of interest are soaked into H.sub.2SO.sub.4 for about 75 seconds. Titanium implants are removed and rinsed with double-distilled H.sub.2O.
Example 2
[0069] Surface profiling was performed for a hierarchically rough titanium surface and comparative titanium surfaces (under a condition with a sampling length of interest being 4 mm and a threshold of 0.8).
[0070] The hierarchically rough titanium showed a remarkably greater average roughness (R.sub.a) of 2.84680.090 m, in comparison with R.sub.a of 0.38140.0233 m for a comparative acid-etched surface, R.sub.a of 0.85080.060 m for a comparative sand-blasted surface, and R.sub.a of 1.0560.094 m for a comparative sand-blasted and acid-etched surface.
[0071] The hierarchically rough titanium showed a remarkably greater average peak-to-valley roughness (R.sub.z or R.sub.p-v) of 13.9850.259 m, in comparison with R.sub.z of 1.9330.147 m for the comparative acid-etched surface, R.sub.z of 4.7900.392 m for the comparative sand-blasted surface, and R.sub.z of 5.9310.543 m for the comparative sand-blasted and acid-etched surface.
[0072] The hierarchically rough titanium showed a remarkably greater average slope of roughness profile (R.sub.a) of 0.36920.0088, in comparison with R.sub.a of 0.06560.0035 for the comparative acid-etched surface, R.sub.a of 0.15040.0097 for the comparative sand-blasted surface, and R.sub.a of 0.18540.0139 for the comparative sand-blasted and acid-etched surface.
Example 3
[0073] A hierarchically rough surface was formed on titanium alloy (Ti-6Al-4V). Specifically, a titanium alloy rod was treated with acid using titanium as an auxiliary material.
[0074] As used herein, the singular terms a, an, and the may include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to an object may include multiple objects unless the context clearly dictates otherwise.
[0075] As used herein, the term set refers to a collection of one or more objects. Thus, for example, a set of objects can include a single object or multiple objects.
[0076] As used herein, the terms substantially and about are used to describe and account for small variations. When used in conjunction with an event or circumstance, the terms can refer to instances in which the event or circumstance occurs precisely as well as instances in which the event or circumstance occurs to a close approximation. For example, when used in conjunction with a numerical value, the terms can refer to a range of variation of less than or equal to 10% of that numerical value, such as less than or equal to 5%, less than or equal to 4%, less than or equal to 3%, less than or equal to 2%, less than or equal to 1%, less than or equal to 0.5%, less than or equal to 0.1%, or less than or equal to 0.05%.
[0077] Additionally, concentrations, amounts, ratios, and other numerical values are sometimes presented herein in a range format. It is to be understood that such range format is used for convenience and brevity and should be understood flexibly to include numerical values explicitly specified as limits of a range, but also to include all individual numerical values or sub-ranges encompassed within that range as if each numerical value and sub-range is explicitly specified. For example, a range of about 1 to about 200 should be understood to include the explicitly recited limits of about 1 and about 200, but also to include individual values such as about 2, about 3, and about 4, and sub-ranges such as about 10 to about 50, about 20 to about 100, and so forth.
[0078] While the disclosure has been described with reference to the specific embodiments thereof, it should be understood by those skilled in the art that various changes may be made and equivalents may be substituted without departing from the true spirit and scope of the disclosure as defined by the appended claims. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, method, operation or operations, to the objective, spirit and scope of the disclosure. All such modifications are intended to be within the scope of the claims appended hereto. In particular, while certain methods may have been described with reference to particular operations performed in a particular order, it will be understood that these operations may be combined, sub-divided, or re-ordered to form an equivalent method without departing from the teachings of the disclosure. Accordingly, unless specifically indicated herein, the order and grouping of the operations are not a limitation of the disclosure.